Mode VC

5AM Ventures

5AM Ventures is a specialist life sciences, healthtech, and deep tech investor that can lead Seed and Series A rounds, based in the U.S., and backed Mendra's $82M Series A.

Website LinkedIn XPortfolioPitch pageTeam page
Entry stageSeed, Series A
Check sizen/a
Leads roundsYes
FocusLife sciences, Healthtech, Deep tech
Latest fund$450M$450M — 5AM Ventures VII, L.P.
Investing team16 peopleNo activity since Sep

Who you would pitch at 5AM Ventures

16 people on the investing team, 5 of them partners who can make the call. Partners are listed first.

Andy J. SchwabManaging Partner
John D. Diekman, PhDFounding PartnerHe is a founding partner at 5AM Ventures.
Kush M Parmar, MD, PhDManaging Partner
Scott M. Rocklage, PhDFounding PartnerHe is a founding partner at 5AM Ventures.
Deborah Palestrant, PhDPartner, Executive Chair, 4:59 InitiativeShe is a Partner and Executive Chair of the 4:59 Initiative at 5AM Ventures.
Katie Bodner Spielberg, PhDPrincipalShe is part of the investment team at the life sciences venture capital firm.
Max Farina, MDPrincipalHe is listed on the team page with the title Principal.
Anna YaegerChief Investment Officer and PartnerShe is also listed as Partner, Head of Public Equities at the firm.
Arthur Tzianabos, PhDVenture Partner
Brian Daniels, MDVenture PartnerHe previously led Development and Medical Affairs at Bristol-Myers Squibb and is based in San Francisco.
Elliott Levy, MDVenture PartnerHe has deep drug development experience from roles at Bristol Myers Squibb and Amgen, and serves on Terray Therapeutics' Scientific Advisory Board.
Joshua GrassVenture PartnerHe was previously CEO of Escient Pharmaceuticals and Modis Therapeutics, and spent 15 years at BioMarin.
Lidia LiuSenior Research AnalystShe is listed on the team page and in fund profiles.
Mason Freeman, MDVenture PartnerHe is listed among the firm's investment professionals in Boston.
Steve Hitchcock, PhDVenture PartnerHe is listed among the firm's investment professionals.
Travis Fleming, PhDAnalyst

Work here and something is wrong? Ask for a correction.

Check size not reported yet.

Bars: how many firms in the atlas report each band. Highlighted: this firm.

No recent activity since September 2026. Quiet does not mean closed.

Weekly count of activity updates. Activity is not a confirmed deal.
Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Alert me when 5AM Ventures is active

One email when this firm shows new activity. Nothing else.

Firms like 5AM Ventures

The Engine$250K to $10M · active Sep 22
Better Ventures$500K to $1M
Bluelake$250K to $3M
Embark Ventures$100K to $3M
Foresite CapitalCheck size not reported
Freeflow VenturesCheck size not reported

On these lists

Seed healthtech investors287Series A healthtech investors243Seed deep tech investors200Seed life sciences investors186Series A life sciences investors167Series A deep tech investors146Seed investors3020Series A investors1867

Questions

What stage does 5AM Ventures invest in?

5AM Ventures reports entry at seed, series a.

How much does 5AM Ventures invest?

5AM Ventures has not reported a check size.

Does 5AM Ventures lead rounds?

Yes. 5AM Ventures says it can lead.

Who are the partners at 5AM Ventures?

Andy J. Schwab (Managing Partner), John D. Diekman, PhD (Founding Partner), Kush M Parmar, MD, PhD (Managing Partner), Scott M. Rocklage, PhD (Founding Partner), Deborah Palestrant, PhD (Partner, Executive Chair, 4:59 Initiative).

Is 5AM Ventures active right now?

No recent activity since September 2026.

Work at 5AM Ventures? Claim or correct this profile.